Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis "ERSIAS"

Recruiting

Phase 2 Results N/A

Summary of Purpose

Stroke due to intracranial arterial atherosclerosis is a significant medical problem, carrying one of the highest rates of recurrent stroke despite best medical therapy, with annual recurrence rates as elevated as 25% in high risk groups. The goal of this investigation is to advance a promising surgical treatment for symptomatic atherosclerotic intracranial stenosis - encephaloduroarteriosynangiosis (EDAS). The ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 October 2017.

1 Mar 2013 24 Mar 2013 1 Jun 2018 1 Jun 2018 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • Patrick Lyden, MD

    310-423-5166

  • Jeffrey Saver, MD

  • Nestor R Gonzalez, MD

See All